Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 2, 1998, Pages 377-386

  Cheng, Dong Hang ^a   Tang, Xi Can ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Alzheimer's disease; Cholinesterase; Cholinesterase inhibitor; E2020; Huperzine A; Learning and memory; Rat radial maze; Tacrine

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; ETHYLCHOLINE MUSTARD AZIRIDINIUM; HUPERZINE A; TACRINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; WORKING MEMORY;

ANIMALS; AZIRIDINES; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDANS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; MEMORY, SHORT-TERM; NEUROMUSCULAR BLOCKING AGENTS; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SESQUITERPENES; TACRINE;

EID: 0032101015     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00601-1     Document Type: Article

References (38)

1. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The colinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
2. Beatty W.W., Carbone C.P. Septal lesions, intramaze cues and spatial behavior in rats. Physiol. Behav. 24:1980;675-678.
3. Bradford M.M. A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Cheng H.C., Ren H., Tang X.C. Huperzine A, a novel promising acetylcholinesterase inhibitor. Neuroreport. 8:1996;97-101.
5. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease. A disorder of cortical cholinergic innervation Science. 219:1983;1184-1190.
6. Davidson M., Stern R.G., Bierer L.M., Horvath T.B., Zemishlani Z., Markofsky R. Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatr. Scand. Suppl. 366:1991;47-51.
7. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1043.
8. Drachman D.A., Leavitt J. Human memory and the cholinergic system. A relationship to aging? Arch. Neurol. 30:1974;113-121.
9. + current. Eur. J. Pharmacol. 141:1987;153-457.
10. Ellman G.L., Courtney K.D., Andre V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
11. Fisher A., Hanin I. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity. Annu. Rev. Pharmacol. Toxicol. 25:1986;161-181.
12. Fisher A., Mantione C.R., Abraham D.J., Hanin I. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (Af64a) in vivo. J. Pharmacol. Exp. Ther. 222:1982;140-145.
13. Fisher, A.; Mantione, C. R.; Grauer, E.; Levy, A.; Hanin, I.: Manipulation of brain cholinergic mechanisms by ethylcholine aziridinium ion (AF64A), a promising animal model for Alzherimer's disease. In: Spiegelstein, M. Y.; Levy, A.; eds. Behavioral models and analysis of drug action. Amsterdam: Elsevier; 1983: 333-342.
14. Francis P.T., Palmer A.M., Sims N.R., Bowen D.M., Davison A.N. Neurochemical studies of early onset Alzheimer's disease. N. Engl. J. Med. 313:1985;7-11.
15. Giacobini, E.; Becker, R.: Development of drugs for Alzhimer therapy: A decade of progress. In: Giacobini, E.; Becker, R.; eds. Alzheimer disease: Therapeutic strategies. Boston: Birkhäuser; 1994:1-7.
16. 3H]-DOPA in various regions of the brain. J. Neurochem. 13:1966;655-659.
17. Hanin, I.: Pharmacological induction of cholinergic hypofunction as a tool for evaluating cholinergic therapies. In: Becker, R.; Giacobini, E.; eds. Alzheimer disease: From molecular biology to therapy. Boston: Birkhäuser; 1996:165-170.
18. Jarrard L.E., Jean Kant G., Meyerhoff J.L., Levy A. Behavioral and neurochemical effects of intraventricular AF64A administration in rats. Pharmacol. Biochem. Behav. 21:1984;273-280.
19. Laganiére S., Corey J., Tang X.C., Wülfert E., Hanin I. Acute and chronic studies with the anticholinesterase huperzine A. Effect on central nervous system cholinergic parameters Neuropharmacology. 30:1991;763-768.
20. Leventer S., Mckeag D., Clancy M., Wulfert E., Hanin I. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (Af64a) reduces release of acetylcholine from rat hippocampal slices. Neuropharmacology. 24:1985;453-459.
21. Lin J.H., Tang Xi. Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro. Acta Pharmacol. Sin. 18:1997;6-10.
22. Liu, J. S.; Zhu, Y. L.; Yu, C. M.; Zhou, Y. Z.; Han, Y. Y.; Wu, F. W.; Qi, B. F.: The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can. J. Chem. 64:837-839: 1986.
23. Mantione C.R., Fisher A., Hanin I. The AF64A-treated mouse. Possible model for central cholinergic hypofunction Science. 213:1981;579-580.
24. Mckinney M., Miller J.H., Yamada F., Tuckmantal W., Kozikowski A.P. Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase. Eur. J. Pharmacol. 203:1991;303-305.
25. Nilsson A., Leanza G., Rosenblad C., Lappi D.A., Robertson D. Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuroreport. 3:1992;1005-1008.
26. Olton D.S., Becker J.T., Handelmann G.E. Hippocampus, space and memory. Behav. Brain Sci. 2:1979;313-365.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, New York.
28. Perry E.K., Simith C.J., Court J.A., Bonham J.R., Rodwary M., Atack J.R. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (Tha) with human cortical nicotinic and muscarinic receptor binding in vitro. Neurosci. Lett. 91:1988;211-216.
29. Perry E.K., Tomlinson B.E., Blessed G, Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1157-1159.
30. Potter P.E., Harsing L.G. Jr., Kakucska I., Gaal G., Vizi E.S. Selective impairment of acetylchloline release and content in the central nervous system following intracerebroventricular administration of ethylcholine mustard aziridinium (Af64a) in the rat. Neurochem. Int. 8:1986;199-206.
31. Rogers, R. L.; Yamanishi, Y.; Yamatsu, K. E2020 - The pharmacology of piperidine cholinesterase inhibitor. In: Becker, R.; Giacobini, E., eds. Cholinergic basis for Alzheimer therapy. Boston: Birkhäuser; 1991:314-320.
32. Tang X.C., De Sarno P., Sugaya K., Giacobini E. Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J. Neurosci. Res. 24:1989;276-285.
33. Tang X.C., Xiong Z.Q., Qian B.C., Zhou Z.F., Zhang C.L. Cognition improvement by oral huperzine A. A novel acetylcholinersterase inhibitor Giacobini E., Becker R. Alzheimer disease. Therapeutic strategies:1994;113-119 Birkhäuser, Boston.
34. Wang Y.E., Yue D.X., Tang X.C. Anti-cholinesterase activity of huperzine A. Acta Pharmacol. Sin. 7:1986;110-113.
35. Watkins P.B., Zimmerman H.J., Knapp M.J., Gracon S.I., Lewis K.W. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA. 271:1994;992-998.
36. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C.T. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with severity of dementia and histological abnormalities J. Neurol. Sci. 57:1982;407-417.
37. Winbald B., Adem A., Bacman L., Nordberg A, Elinder F., Arhem P. Cholinesterase inhibitors in Alzheimer's disease. Evaluation of clinical studies Berker B., Giacobini E. Cholinergic basis for Alzheimer therapy. 1991;238-243 Birkhäuser, Boston.
38. Wirsching B.A., Beninger R.J., Jhamandas K., Boegman R.J., El-Defrawy S.R. Differential effects of scopolamine on working and reference memory of rats in the radial maze. Pharmacol. Biochem. Behav. 20:1984;659-662.